Insiders Humanigen, Inc.

Equities

Market Closed - OTC Markets Other stock markets 20:48:43 28/06/2024 BST			5-day change	1st Jan Change
0.000001 ^USD	-99.50%		-99.50%	-99.92%

05-01	Combined Hearing for Disclosure Statement and Plan Approved for Humanigen, Inc.	CI
04-12	Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc.	CI

Xspray Pharma Names Chief Commercial Officer	15/09/23	MT
Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer	14/09/23	CI
Humanigen, Inc. Announces Board Changes	25/07/23	CI
Opthea Appoints CFO	25/10/22	MT
Opthea Appoints Timothy Morris as CFO	24/10/22	MT
Humanigen, Inc. Announces Executive Changes	29/09/22	CI
Humanigen Chief Medical Officer Adrian Kilcoyne Resigns	02/09/22	MT
Humanigen, Inc. Announces Resignation Adrian Kilcoyne as Chief Medical Officer, Effective September 28, 2022	02/09/22	CI
Insider Buy: Humanigen	23/05/22	MT
Insider Buy: Humanigen	16/03/22	MT
Humanigen, Inc. Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors	20/10/21	CI
Humanigen : Says EMA Appointed Rapporteurs for Pre-Submission Process for COVID-19 Drug Lenzilumab	28/09/21	MT
Insider Trends: Humanigen Insider Extends 90-Day Selling Trend	14/08/21	MT
Insider Trends: Insider Prolongs 90-Day Selling Trend at Humanigen	31/07/21	MT
Insider Trends: Insider 90-Day Selling Trend Extended at Humanigen	24/07/21	MT
Insider Trends: Insider 90-Day Selling Trend Extended at Humanigen	17/07/21	MT
Insider Trends: Insider 90-Day Selling Trend Extended at Humanigen	10/07/21	MT
Insider Trends: Insider Prolongs 90-Day Selling Trend at Humanigen	02/07/21	MT
Insider Trends: 90-Day Insider Selling Trend Prolonged at Humanigen	26/06/21	MT
Insider Trends: Humanigen Insider Extends 90-Day Selling Trend	22/06/21	MT

No results for this search